Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$19.51 - $27.64 $12.7 Million - $18 Million
-649,516 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$13.77 - $21.66 $8.94 Million - $14.1 Million
649,516 New
649,516 $13.9 Million
Q4 2020

Feb 16, 2021

SELL
$10.75 - $14.91 $6.39 Million - $8.87 Million
-594,750 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$11.98 - $16.34 $7.13 Million - $9.72 Million
594,750 New
594,750 $7.54 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.14B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.